32
Participants
Start Date
August 4, 2025
Primary Completion Date
October 30, 2025
Study Completion Date
June 30, 2026
Indole-3-propionic acid (IPA)
Two capsules are taken every morning and two capsules are taken every evening for 14 consecutive days. Active capsules are taken orally and contain 250 mg of IPA each.
Placebo
Two capsules are taken every morning and two capsules are taken every evening for 14 consecutive days. Placebo capsules are taken orally and contain maltodextrin.
RECRUITING
Optic Neuritis Clinic, Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital, Rigshospitalet-Glostrup, Glostrup Municipality
University of Copenhagen
OTHER
University of Southampton
OTHER
Glostrup University Hospital, Copenhagen
OTHER